Trial site
Instituto Di Ricovero E Cura A Carattere Scientifico
- 11running trials
- 6closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Narcolepsy7 trials
- Chronic rhinosinusitis with nasal polyps2 trials
- Glioblastoma2 trials
- Myasthenia gravis2 trials
- Epilepsy1 trial
- Head and neck cancer1 trial
- Meningioma1 trial
- Migraine1 trial
- Phase
- Phase 311 trials
- Phase 24 trials
- Phase 2/31 trial
- Phase 41 trial
- Status
- Recruiting9 trials
- Completed6 trials
- Active, not recruiting2 trials
- Lead sponsor
- Alkermes Inc.3 trials
- Alkermes, Inc.3 trials
- European Organisation for Research and Treatment of Cancer - EORTC3 trials
- Sanofi2 trials
- AbbVie1 trial
- and 5 more
Running trials
Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Recruiting
Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer
Recruiting
Active, not recruiting
Recruiting
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Recruiting
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients with Myasthenia Gravis
Recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Narcolepsy4 recruiting
- Myasthenia gravis2 recruiting
- Glioblastoma1 recruiting
- Head and neck cancer1 recruiting
- Meningioma1 recruiting
Closed trials
Active, not recruiting
Completed
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 2
Completed
Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine
Completed
Completed
Completed
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026